Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 28, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 28, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 1,367 Common Stock at $523.15 ($715,152) on July 28, 2026; holds 332,576 after (Indirect).
- Open-market sale: disposed of 1,074 Common Stock at $524.04 ($562,818) on July 28, 2026; holds 331,502 after (Indirect).
- Open-market sale: disposed of 876 Common Stock at $525.02 ($459,918) on July 28, 2026; holds 330,626 after (Indirect).
- Open-market sale: disposed of 1,473 Common Stock at $526.34 ($775,295) on July 28, 2026; holds 329,153 after (Indirect).
- Open-market sale: disposed of 1,369 Common Stock at $527.16 ($721,678) on July 28, 2026; holds 327,784 after (Indirect).
- Open-market sale: disposed of 1,149 Common Stock at $528.20 ($606,905) on July 28, 2026; holds 326,635 after (Indirect).
- Open-market sale: disposed of 625 Common Stock at $529.41 ($330,882) on July 28, 2026; holds 326,010 after (Indirect).
- Open-market sale: disposed of 1,124 Common Stock at $530.29 ($596,048) on July 28, 2026; holds 324,886 after (Indirect).
- Open-market sale: disposed of 403 Common Stock at $530.97 ($213,981) on July 28, 2026; holds 324,483 after (Indirect).
- Open-market sale: disposed of 40 Common Stock at $532.49 ($21,300) on July 28, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 28, 2026; holds 255,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,003,976 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-07-28 | Open-market sale | Common Stock | 1,367 | $523 | $715.2K | 332,576 |
| 2026-07-28 | Open-market sale | Common Stock | 1,074 | $524 | $562.8K | 331,502 |
| 2026-07-28 | Open-market sale | Common Stock | 876 | $525 | $459.9K | 330,626 |
| 2026-07-28 | Open-market sale | Common Stock | 1,473 | $526 | $775.3K | 329,153 |
| 2026-07-28 | Open-market sale | Common Stock | 1,369 | $527 | $721.7K | 327,784 |
| 2026-07-28 | Open-market sale | Common Stock | 1,149 | $528 | $606.9K | 326,635 |
| 2026-07-28 | Open-market sale | Common Stock | 625 | $529 | $330.9K | 326,010 |
| 2026-07-28 | Open-market sale | Common Stock | 1,124 | $530 | $596.0K | 324,886 |
| 2026-07-28 | Open-market sale | Common Stock | 403 | $531 | $214.0K | 324,483 |
| 2026-07-28 | Open-market sale | Common Stock | 40 | $532 | $21.3K | 324,443 |
| 2026-07-28 | Option exercise/conversion | Stock Option | 9,500 | — | — | 255,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Option exercise/conversion (9,500 shares) |
| 2026-07-28 | Open-market sale (1,367 shares) |
| 2026-07-28 | Open-market sale (1,074 shares) |
| 2026-07-28 | Open-market sale (876 shares) |
| 2026-07-28 | Open-market sale (1,473 shares) |
| 2026-07-28 | Open-market sale (1,369 shares) |
| 2026-07-28 | Open-market sale (1,149 shares) |
| 2026-07-28 | Open-market sale (625 shares) |
| 2026-07-28 | Open-market sale (1,124 shares) |
| 2026-07-28 | Open-market sale (403 shares) |
| 2026-07-28 | Open-market sale (40 shares) |
| 2026-07-28 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.